Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 16.96%17.94B | 11.75%15.34B | 18.59%5.08B | 4.19%2.78B | 15.47%13.73B | 4.47B | 7.63%2.3B | 33.32%4.28B | -3.38%2.67B | 2.70%11.89B |
| Cost of revenue | 17.17%11.2B | 4.85%9.56B | 11.11%3.21B | -1.46%1.71B | 14.93%9.12B | 2.89B | 9.31%1.61B | 33.44%2.89B | -4.68%1.74B | -0.34%7.93B |
| Gross profit | 16.63%6.74B | 25.35%5.78B | 34.02%1.87B | 14.66%1.07B | 16.54%4.61B | 1.59B | 3.94%693.64M | 33.07%1.39B | -0.88%935.62M | 9.40%3.96B |
| Operating expense | 12.56%4.42B | 17.36%3.93B | 21.71%897.97M | 9.48%827.03M | 6.79%3.34B | 1B | 19.11%848.21M | -2.71%737.82M | 1.89%755.43M | 22.83%3.13B |
| Staff costs | 11.27%1.66B | 21.77%1.49B | ---- | ---- | 5.30%1.22B | ---- | ---- | ---- | ---- | 1.99%1.16B |
| Selling and administrative expenses | 49.58%531M | 6.40%355M | ---- | ---- | 14.48%333.66M | ---- | ---- | ---- | ---- | 26.13%291.45M |
| -Selling and marketing expense | 76.54%316M | -2.31%179M | ---- | ---- | 3.75%183.23M | ---- | ---- | ---- | ---- | 20.73%176.6M |
| -General and administrative expense | 22.16%215M | 17.00%176M | ---- | ---- | 30.99%150.43M | ---- | ---- | ---- | ---- | 35.44%114.85M |
| Research and development costs | 7.90%792M | 4.27%734M | ---- | ---- | -9.14%703.96M | ---- | ---- | ---- | ---- | 97.34%774.74M |
| Depreciation and amortization | 24.39%153M | 18.79%123M | ---- | ---- | 46.92%103.54M | ---- | ---- | ---- | ---- | 13.10%70.48M |
| -Depreciation | 24.39%153M | 18.79%123M | ---- | ---- | 46.92%103.54M | ---- | ---- | ---- | ---- | 21.24%70.48M |
| Rent and land expenses | 4.55%92M | 7.54%88M | ---- | ---- | 0.76%81.83M | ---- | ---- | ---- | ---- | 4.16%81.21M |
| Other operating expenses | 5.03%1.19B | 26.44%1.13B | ---- | ---- | 19.44%896.84M | ---- | ---- | ---- | ---- | 16.32%750.89M |
| Operating profit | 25.23%2.32B | 46.44%1.86B | 47.87%970.3M | 36.36%245.71M | 53.54%1.27B | 584.98M | -244.94%-154.57M | 126.91%656.16M | -11.02%180.19M | -22.69%825.02M |
| Net non-operating interest income (expenses) | -22M | 0 | -209.99%-1.37M | 80.03%-635K | 70.20%-5.92M | -4.27M | 106.32%294K | 124.69%1.24M | 40.91%-3.18M | 18.79%-19.86M |
| Non-operating interest income | -16.67%15M | 61.12%18M | -103.53%-130K | 1.07%1.13M | 2,986.19%11.17M | --4.07M | 2,492.13%2.31M | 5,310.29%3.68M | 7,353.33%1.12M | -15.22%362K |
| Non-operating interest expense | 105.56%37M | 5.32%18M | -49.34%1.24M | -58.92%1.77M | -15.48%17.09M | --8.34M | -57.56%2.01M | -52.14%2.44M | -20.35%4.3M | -18.73%20.22M |
| Net investment income | 1,000.00%270M | -109.40%-30M | 103.70%135.17M | -38.56%-66.17M | -23.50%319.11M | 74.9M | 37.73%225.61M | -57.98%66.36M | -184.79%-47.75M | 181.23%417.13M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -76.07%19.77M | 0 | 82.61M | ||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 17M | 0 | -308.99%-721K | 721K | -568.63%-178.68M | 551K | -1,496,333.33%-179.57M | 345K | 0 | -16.74%38.13M |
| Less:Other special charges | -70,733.33%-17M | -100.02%-24K | ---- | ---- | 489.72%148.59M | ---1.26M | 1,251,491.67%150.19M | ---- | ---- | 16.74%-38.13M |
| Less:Write off | --0 | --0 | --721K | ---721K | --30.09M | --707K | --29.38M | --0 | --0 | --0 |
| Other non-operating income (expenses) | -83.78%6M | 52.29%37M | 13.95%8.85M | 369.90%11.15M | 58.29%24.3M | 6.36M | 304.09%7.8M | 539.51%7.77M | -56.27%2.37M | -87.12%15.35M |
| Income before tax | 39.50%2.59B | 28.21%1.85B | 51.97%1.11B | 44.93%190.77M | 6.40%1.45B | 662.5M | -169.39%-80.67M | 61.20%731.88M | -64.32%131.63M | 0.17%1.36B |
| Income tax | 53.07%649M | 32.84%424M | 58.70%280.97M | -218.81%-64.97M | 10.96%319.18M | 113.95M | -188.73%-26.49M | 52.98%177.04M | -56.16%54.68M | -26.42%287.66M |
| Net income | 35.50%1.94B | 26.80%1.43B | 49.64%830.26M | 232.36%255.74M | 5.18%1.13B | 548.56M | -143.19%-54.18M | 64.01%554.83M | -68.49%76.95M | 10.95%1.07B |
| Net income continuous operations | 35.48%1.94B | 26.89%1.43B | 49.82%831.26M | 232.36%255.74M | 5.18%1.13B | --548.55M | -143.19%-54.18M | 64.01%554.83M | -68.49%76.95M | 10.95%1.07B |
| Noncontrolling interests | -82.65%4.82M | |||||||||
| Net income attributable to the company | 35.50%1.94B | 26.80%1.43B | 49.64%830.26M | 232.36%255.74M | 5.65%1.13B | 548.56M | -143.23%-54.18M | 65.39%554.83M | -68.25%76.95M | 13.72%1.07B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 35.50%1.94B | 26.80%1.43B | 49.64%830.26M | 232.36%255.74M | 5.65%1.13B | 548.56M | -143.23%-54.18M | 65.39%554.83M | -68.25%76.95M | 13.72%1.07B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 37.10%121.68 | 28.42%88.75 | 48.63%50.61 | 231.99%15.67 | 5.64%69.11 | 33.66 | -143.17%-3.32 | 65.37%34.05 | -68.26%4.72 | 13.73%65.42 |
| Diluted earnings per share | 37.10%121.68 | 28.42%88.75 | 48.63%50.61 | 231.99%15.67 | 5.64%69.11 | 33.6593 | -143.24%-3.3252 | 65.38%34.05 | -68.26%4.72 | 13.73%65.42 |
| Dividend per share | 50.00%30 | 66.67%20 | 0 | 0 | 20.00%12 | 12 | 0 | 0 | 0 | 17.65%10 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |